(Q54106641)

24 May 2018

title

Risk factors for rifampin-monoresistant tuberculosis: A case-control study. (English)

1 reference

24 May 2018

0 references

Sandman L

1

1 reference

24 May 2018

Schluger NW

series ordinal

2

1 reference

24 May 2018

Davidow AL

series ordinal

3

1 reference

24 May 2018

Bonk S

series ordinal

4

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 February 1999

1 reference

24 May 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

24 May 2018

volume

159

1 reference

24 May 2018

issue

2

1 reference

24 May 2018

page(s)

468-472

1 reference

24 May 2018

Acquired Drug Resistance inMycobacterium tuberculosisIsolates Recovered from Compliant Patients with Human Immunodeficiency Virus–Associated Tuberculosis

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.2.9805097

The emergence of drug-resistant tuberculosis in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.2.9805097

Brief report: rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.2.9805097

Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.2.9805097

Rifampin-monoresistant tuberculosis in New York City, 1993-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.2.9805097

Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.2.9805097

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.2.9805097

Risk Factors for Rifampin Mono-resistant Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.2.9805097

10.1164/AJRCCM.159.2.9805097

21 January 2018

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018